Published in Gene Therapy Weekly, August 9th, 1999
R. Stripecke and colleagues from the Children's Hospital at Los Angeles and the University of Southern California School of Medicine, California, investigated GFP in vivo for any potential immune response ("Immune Response to Green Fluorescent Protein: Implications for Gene Therapy," Gene Therapy, July 1999;6(7):1305-12).
"Development of immune responses to transgenes may be an important impediment to successful gene therapy," wrote Stripecke et al. "To our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.